← Leaderboards
Joseph M. Hyser
Baylor College Of Medicine
$6,166,803
Attributed
$9,087,252
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,087,252 · 6
By mechanism
R01$7,849,171 · 3
K01$639,070 · 1
R21$440,511 · 1
R03$158,500 · 1
Top collaborators
- Sue Ellen Crawford5 shared
- Mary Kolb Estes5 shared
- Christine Beeton3 shared
- Robert A Britton3 shared
- Tibor Farkas2 shared
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Christine Beeton$7,582,844
- Mary Kolb Estes$39,670,172
- Sue Ellen Crawford$2,531,734
- James J Dowling$5,395,475
- Brendan Hl Lee$62,781,623
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingIntestinesCellsEnteralInsightRotavirusViralDiarrheaVirusEndoplasmic ReticulumNonstructural ProteinSignal PathwayVirus ReplicationPathogenesisRotavirus InfectionsPathogenCessation Of LifeHomeostasisChildMolecularSignal TransductionPathway InteractionsIon ChannelProteins
Grant awards (26)
Engineered probiotic for the treatment of autoimmune diseases$692,859
R01 · FY2025 · AI
Enteric virus exploitation of calcium signaling$640,765
R01 · FY2025 · DK · contact PI
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways$400,000
R01 · FY2025 · AI · contact PI
Engineered probiotic for the treatment of autoimmune diseases$675,152
R01 · FY2024 · AI
Enteric virus exploitation of calcium signaling$632,030
R01 · FY2024 · DK · contact PI
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways$400,000
R01 · FY2024 · AI · contact PI
Training Supplement in Enteric Virus Exploitation of Calcium Signaling$89,658
R01 · FY2024 · DK · contact PI
Engineered probiotic for the treatment of autoimmune diseases$682,280
R01 · FY2023 · AI
Enteric virus exploitation of calcium signaling$644,109
R01 · FY2023 · DK · contact PI
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways$400,000
R01 · FY2023 · AI · contact PI
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways$400,000
R01 · FY2022 · AI · contact PI
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling$355,786
R01 · FY2022 · DK · contact PI
Dissecting Rotavirus Viroporin and Enterotoxin Calcium Signaling Pathways$400,000
R01 · FY2021 · AI · contact PI
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling$355,809
R01 · FY2021 · DK · contact PI
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling$355,832
R01 · FY2020 · DK · contact PI
Enteric Calicivirus Viroporin-Mediated Calcium Signaling$232,166
R21 · FY2020 · AI · contact PI
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling$362,501
R01 · FY2019 · DK · contact PI
Enteric Calicivirus Viroporin-Mediated Calcium Signaling$208,345
R21 · FY2019 · AI · contact PI
Enteric Virus Exploitation of Store-operated and Purinergic Calcium Signaling$362,390
R01 · FY2018 · DK · contact PI
Regulation of Enteric Virus Secretory Diarrhea$79,250
R03 · FY2018 · DK · contact PI
Regulation of Enteric Virus Secretory Diarrhea$79,250
R03 · FY2017 · DK · contact PI
Enteric Virus Calcium Channel Inhibitors$147,442
K01 · FY2016 · DK · contact PI
Enteric Virus Calcium Channel Inhibitors$122,907
K01 · FY2015 · DK · contact PI
Enteric Virus Calcium Channel Inhibitors$122,907
K01 · FY2014 · DK · contact PI
Enteric Virus Calcium Channel Inhibitors$122,907
K01 · FY2013 · DK · contact PI
Enteric Virus Calcium Channel Inhibitors$122,907
K01 · FY2012 · DK · contact PI